全文获取类型
收费全文 | 37740篇 |
免费 | 2431篇 |
国内免费 | 1022篇 |
专业分类
耳鼻咽喉 | 252篇 |
儿科学 | 1063篇 |
妇产科学 | 319篇 |
基础医学 | 8458篇 |
口腔科学 | 364篇 |
临床医学 | 3302篇 |
内科学 | 5115篇 |
皮肤病学 | 684篇 |
神经病学 | 1335篇 |
特种医学 | 750篇 |
外国民族医学 | 3篇 |
外科学 | 4674篇 |
综合类 | 5537篇 |
现状与发展 | 5篇 |
预防医学 | 2793篇 |
眼科学 | 188篇 |
药学 | 3228篇 |
19篇 | |
中国医学 | 1172篇 |
肿瘤学 | 1932篇 |
出版年
2024年 | 50篇 |
2023年 | 527篇 |
2022年 | 1194篇 |
2021年 | 1438篇 |
2020年 | 1127篇 |
2019年 | 1119篇 |
2018年 | 1068篇 |
2017年 | 1064篇 |
2016年 | 1131篇 |
2015年 | 1142篇 |
2014年 | 2018篇 |
2013年 | 2303篇 |
2012年 | 1950篇 |
2011年 | 2183篇 |
2010年 | 1584篇 |
2009年 | 1606篇 |
2008年 | 1575篇 |
2007年 | 1742篇 |
2006年 | 1463篇 |
2005年 | 1428篇 |
2004年 | 1244篇 |
2003年 | 1148篇 |
2002年 | 952篇 |
2001年 | 896篇 |
2000年 | 867篇 |
1999年 | 681篇 |
1998年 | 675篇 |
1997年 | 673篇 |
1996年 | 607篇 |
1995年 | 698篇 |
1994年 | 604篇 |
1993年 | 553篇 |
1992年 | 515篇 |
1991年 | 495篇 |
1990年 | 413篇 |
1989年 | 292篇 |
1988年 | 322篇 |
1987年 | 254篇 |
1986年 | 206篇 |
1985年 | 378篇 |
1984年 | 257篇 |
1983年 | 210篇 |
1982年 | 141篇 |
1981年 | 108篇 |
1980年 | 65篇 |
1979年 | 61篇 |
1978年 | 46篇 |
1977年 | 29篇 |
1976年 | 22篇 |
1974年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
目的建立单抗N糖分析方法的系统适用性对照品,并设定相应的系统适用性要求。方法利用液质联用(LC-MS)仪对N糖系统适用性对照品进行N糖型的表征鉴别,并对对照品进行稳定性评价。结合方法特点和验证数据,对系统适用性要求进行设定。结果建立的系统适用性对照品具有良好的稳定性,其糖型涵盖了单抗主要的N糖型种类。针对3种药典拟收录的单抗N糖分析方法,设定了以下系统适用性要求,包括:图谱与典型图谱相似、G1F(1,6)和G1F(1,3)的分离度应满足具体要求、G0F%应在规定的范围内、G0F保留时间的RSD应≤4%。结论建立了单抗N糖系统适用性对照品,可配合3种2020年版《中国药典》拟收录的N糖分析方法使用。 相似文献
22.
23.
24.
25.
Is it possible to make a diagnosis of raw,heated, and baked egg allergy in children using cutoffs? A systematic review
下载免费PDF全文
![点击此处可从《Pediatric allergy and immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
26.
《Revista espa?ola de anestesiología y reanimación》2022,69(9):517-525
Background and objectivesThe ideal timing of tranexamic acid administration in total knee arthroplasty with tourniquet remains unclear. Our primary objective was to prove if administering it before surgical incision, instead of before releasing the tourniquet, reduces postoperative bleeding. A second objective was to determine whether a second dose reduces post-operative bleeding.Material and methodsA prospective, double-blind clinical trial was performed on 212 patients scheduled for total knee arthroplasty. They were randomised into 4 groups. Tranexamic acid was administered before the surgical incision in “pre-induction groups” (1 and 2), and just before the tourniquet release in “pre-release groups” (3 and 4). Groups 2 and 4 received a second dose 3 hours post-surgery. Main outcome was postoperative bleeding (visible blood loss and calculated total bleeding). Secondary outcomes were haemoglobin variations, complications and transfusion rate.ResultsThe mean calculated total bleeding was 1563 ml (95%CI: 1445 to 1681) in preinduction groups versus 1576 ml (95%CI: 1439 to 1713) in pre-release groups (P = .9); 1579 ml (95%CI: 1452 to 1706) in single-dose groups versus 1559 ml (95%CI: 1431 to 1686) in double-dose groups (P = .82). One patient was transfused. The mean haemoglobin at discharge was 10.4 g/dl (95%CI: 10.2 to 10.7) in singledose groups versus 10.8 (95%CI: 10.6 to 11.1) in double-dose groups (P = .06).ConclusionsThere were no differences in bleeding or transfusion regarding the time of tranexamic acid administration. The second dose had not impact on outcomes.Trial registration: EudraCT 2016-000071-24. 相似文献
27.
裴宇 《中国继续医学教育》2020,(13):131-133
目的探讨他克莫司联合308nm准分子激光在面部白癜风治疗中的应用效果。方法选取2017年2月-2019年2月医院84例面部白癜风患者为研究对象,根据入院单双号将受试者进行分组,其中对照组42例患者接受308nm准分子激光治疗,研究组42例患者在对照组的基础上联合他克莫司软膏治疗,比较两组患者治疗后1个月、3个月时的治疗总有效率以及治疗前后白斑面积与皮损区IL-17水平变化。结果研究组患者在治疗后1个月、3个月时的治疗总有效率均显著高于对照组(P<0.05),与治疗前相比,治疗后两组患者白斑面积及皮损区IL-17水平均显著减少,且研究组显著少于对照组(P<0.05)。结论他克莫司联合308nm准分子激光可有效缩小白斑面积,降低皮损区IL-17水平,疗效确切。 相似文献
28.
29.
30.
R. Asero A. V. Marzano S. Ferrucci M. Lorini V. Carbonelli M. Cugno 《Clinical and experimental immunology》2020,200(3):242-249
Chronic spontaneous urticaria (CSU) pathogenesis shows a complex and still unclear interplay between immunoglobulin (Ig)G- and IgE-mediated autoimmunity, leading to mast cell and basophil degranulation and wheal formation. The objective of this study was to evaluate at the same time IgE- and IgG-reactivity to well recognized and recently reported autoantigens in CSU patients, and to assess the effects of such reactivity on response to the anti-IgE monoclonal antibody omalizumab. Twenty CSU patients underwent omalizumab treatment. Urticaria activity score 7 (UAS7) was recorded at baseline and at different drug administration time-points for categorizing early-, late- or non-responders. At baseline, sera from the 20 patients and from 20 controls were tested for IgE and IgG autoantibodies to high- and low-affinity IgE receptors (FcεRI and FcεRII), tissue factor (TF) and thyroglobulin (TG) by immunoenzymatic methods. Antibody levels were compared with those of controls and analysed according to response. Eighteen patients were omalizumab responders (11 early and seven late), while two were non-responders. More than 50% of patients had contemporary IgE and IgG to at least to one of the four different autoantigens. Late responders showed higher levels of both anti-TF IgE and IgG than early responders (P = 0·011 and P = 0·035, respectively). Twenty-five per cent of patients had levels of anti-FcεRI IgE, exceeding the upper normal limit, suggesting that it could be a novel auto-allergen in CSU. In CSU, there is an autoimmune milieu characterized by the co-existence of IgE and IgG autoantibodies to the same antigen/allergen, particularly in late responders to omalizumab, possibly explaining the slower response. 相似文献